Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Common Stock | Options Exercise | $320K | +17.5K | +291.67% | $18.29* | 23.5K | Mar 28, 2024 | Direct | |
transaction | CRNX | Common Stock | Sale | -$812K | -17.5K | -74.47% | $46.38 | 6K | Mar 28, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Stock Option (right to buy) | Options Exercise | $0 | +17.5K | $0.00* | 0 | Mar 28, 2024 | Common Stock | 17.5K | $18.29 | Direct | F2 |
Id | Content |
---|---|
F1 | The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $46.38 per share. The range of sales prices on the transaction date was $46.06 to $46.66 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. |
F2 | The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. |